Trial NCT02871323

View at ClinicalTrials.gov 
Org. Study IDs: NU 16H05
Secondary IDs: NCI-2016-01024 NU 16H05 P30CA060553 STU00202833

Last trial update was posted on 2019-08-20

MeSH Interventions

Antibodies, Monoclonal Durvalumab Immunoglobulin G Immunoglobulins

MeSH Conditions

Polycythemia Polycythemia Vera Primary Myelofibrosis

Other Conditions

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Stopping Reasons

PI decided to withdraw the study after it opened for enrollment but before any patients were enrolled

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID